UCB at BioTechX Europe 2026

Oct 6–8, 2026 Basel, Switzerland ~3k attendees Website

UCB takes part in 4 sessions at BioTechX Europe 2026 in Basel. Its sessions centre on real-world evidence, meaning data gathered from routine patient care, and on getting data ready for AI. Specific topics include using strategic foresight to decide which AI uses in real-world evidence come first, and the value of such evidence in rare diseases.

OrganizationBioTechX Europe 2026 Attendance
UCB
Brussels, Belgium
ucb.com
Large pharma
Belgian biopharmaceutical company developing medicines for immunological and neurological diseases.
Talk
Tue Oct 6
16:10
Strategic foresight for prioritisation of AI applications in RWE
Real World Data and Evidence
Panel
Tue Oct 6
17:25
Data Management & Readiness for AI
Data Management, Storage and Architecture · with Roche, AstraZeneca, Syngenta
Chair
Wed Oct 7
09:05
Chair's remarks
Keynotes
Panel
Wed Oct 7
16:30
Importance of real-world evidence for rare diseases
Real World Data and Evidence · with Novartis, IPQ Analytics, University of Alabama at Birmingham +1 more

Explore the full BioTechX Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full BioTechX Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from UCB

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or BioTechX. Submit a correction